A ONCE-DAILY ORAL JAK inhibitor indicated for the treatment of adults and pediatric patients 12+ years of age with refractory, moderate to severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies are inadvisable.1

DOWNLOADABLE

R E S O U R C E S

Help your patients start and stay on track with their prescribed treatment.
Explore resources and download the forms you need to get started.

 

 

Patient Resources

Use this helpful discussion guide to talk with your patient about benefits and safety considerations.

Use this helpful discussion guide to talk with your patient about benefits and safety considerations.

Find more resources for initiation, prior authorization, and patient support